The NBA has issued a 25-game suspension without pay to Milwaukee Bucks forward Bobby Portis Jr. after he tested positive for Tramadol, a painkiller prohibited under the league’s anti-drug policy. The suspension will prevent Portis from participating in games until at least April 8, when the Bucks are set to face the New York Knicks.
This suspension begins with Thursday’s match against the LA Clippers, marking a significant absence for Portis, who has been a critical contributor to the team this season, averaging 13.7 points and 8.3 rebounds per game.
Portis’s agent, Mark Bartelstein, explained that the player took the substance unknowingly, believing he was using Toradol, which is allowed in the league. Bartelstein expressed disappointment with the league’s strict interpretation of its policy, stating that Portis had no intention of violating the rules and is saddened by the outcome of what he considers an honest mistake. He emphasized Portis’s commitment to his role in the NBA and as a representative of the Bucks and the city of Milwaukee.
Despite the setback, Bartelstein noted that Portis intends to approach this challenge positively, seizing the opportunity to enhance both his performance and reputation during his time away from the court.
As the NBA continues to enforce its anti-drug policies rigorously, this case serves as a reminder of the complexities athletes face regarding prescribed substances. The hope is that Portis will return stronger and even more dedicated to his role within his team and the community.